Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 8, Number 2, March 2010

Articles

Favourites:
ADD

Obesity and Arterial Compliance Alterations
pp. 155-168(14)
Authors: Seifalian, Alexander M.; Filippatos, Theodosios D.; Joshi, Jatin; Mikhailidis, Dimitri P.

Favourites:
ADD

Endothelial Dysfunction in Cardiac Allograft Vasculopathy: Potential Pharmacological Interventions
pp. 169-188(20)
Authors: Osto, Elena; Tona, Francesco; Bon, Emiliano D.; Iliceto, Sabino; Cella, Guiseppe

Favourites:
ADD

Impact of the Renin-Angiotensin-Aldosterone-System on Cardiovascular and Renal Complications in Diabetes Mellitus
pp. 189-197(9)
Authors: Hayashi, Tetsuya; Takai, Shinji; Yamashita, Chika

Favourites:
ADD

Animal Models for Studying Neointima Formation
pp. 198-219(22)
Authors: Jeremy, Jamie Y.; Thomas, Anita C.

Favourites:
ADD

Free Content Characterization of Molecular and Functional Alterations of Tumor Endothelial Cells to Design Anti-Angiogenic Strategies
pp. 220-232(13)
Authors: Bussolati, Benedetta; Deregibus, Maria C.; Camussi, Giovanni

Favourites:
ADD

Macrophage Heterogeneity: Relevance and Functional Implications in Atherosclerosis
pp. 233-248(16)
Authors: Stoger, J. L.; Goossens, Pieter; de Winther, Menno P.J.

Favourites:
ADD

Cardiovascular Effects of Endogenous Estrogen and Hormone Therapy
pp. 249-258(10)
Authors: Bechlioulis, Aris; Naka, Katerina K.; Calis, Karim A.; Makrigiannakis, Antonis; Michalis, Lampros; Kalantaridou, Sophia N.

Favourites:
ADD

Reactive Oxygen Species and Antioxidants in the Pathophysiology of Cardiovascular Disease: Does the Actual Knowledge Justify a Clinical Approach?
pp. 259-275(17)
Authors: Rosa, Salvatore D.; Cirillo, Plinio; Paglia, Antonella; Sasso, Laura; Palma, Vito Di; Chiariello, Massimo

Favourites:
ADD

Gender Bias in Acute Coronary Syndromes
pp. 276-284(9)
Authors: Bugiardini, Raffaele; Navarro Estrada, Jose L.; Nikus, Kjell; Hall, Alistair S.; Manfrini, Olivia

Favourites:
ADD

Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis
pp. 285-292(8)
Authors: Cugno, Massimo; Ingegnoli, Francesca; Gualtierotti, Roberta; Fantini, Flavio

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more